Categories: Wire Stories

Nagoya Anesthesia Clinic Initiates Inbound Medical Treatment for Treatment-Resistant Depression and Intractable Chronic Pain Using Ketamine

NAGOYA, Japan–(BUSINESS WIRE)–Nagoya Anesthesia Clinic (https://nagoyamasui.com/), located in Nagoya City, Aichi Prefecture, Japan, has commenced inbound medical treatment for treatment-resistant depression, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), and intractable chronic pain, utilizing the groundbreaking drug, Ketamine, starting in October 2023. In addition, the clinic offers other innovative procedures such as Echo-Guided Botox treatment for stiff neck and EchoGuided PRP therapy for tennis elbow.

Ketamine, a widely used general anesthetic dating back to over 50 years ago, has also been employed in the United States for the treatment of mental disorders and chronic pain for the past decade. Unlike conventional medications, which can take time to alleviate symptoms, Ketamine offers rapid symptom relief within hours to up to three weeks of administration. Moreover, it is associated with minimal long-term side effects, making it a promising treatment modality.

Nagoya Anesthesia Clinic, with its rich experience of performing over 1000 Ketamine infusions for various pain and mental disorders, has launched the Ketamine Clinic based on Ketamine’s potent analgesic and antidepressant properties. Ketamine infusions are typically administered in sets of 3 to 6 sessions over a span of 1 to 3 weeks, followed by a maintenance therapy once a month, a regimen notable for its low incidence of long-term side effects.

Nagoya Anesthesia Clinic is proud to be the first and only Ketamine Clinic in Japan and will begin accepting patients for inbound medical treatment of treatment-resistant depression, OCD, PTSD, and intractable chronic pain from October 2023. Building upon their Ketamine infusion experience dating back to 2010, they aim to support individuals struggling with treatment-resistant conditions through innovative, evidence-based, and compassionate approaches.

Nagoya Anesthesia Clinic “Ketamine Clinic” Information Page:

https://nagoyamasui.com/ketamine3

“Stiff Neck Botox” Information Page:

https://nagoyamasui.com/botox3

“Tennis Elbow PRP Therapy” Information Page:

https://nagoyamasui.com/prp3

Contacts

For inquiries, please contact:

JTB Medical & Healthcare:

jmhc_info@j-medical-healthcare.com

Alex

Recent Posts

Over 60 Innovations presented by Hong Kong Innovation & Invention Go-Global at the Geneva International Exhibition of Inventions 2025

10+ conceptual inventions from student teams of primary and secondary schools in Hong Kong were…

1 hour ago

Asia-Pacific Megatrends Report 2025-2035: Impacts of Business Model Transformation, Economic and Political Shifts, and Social Evolution – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Growth Opportunities Driven by Megatrends in Asia-Pacific, Forecast to 2035" report has been…

2 days ago

China Shared Mobility Market Research Report 2023-2025 & 2030: Travel Efficiency and Safety Driving Growth Across Ridehailing, Ridesharing, Bikesharing, and Car Rental – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Shared Mobility Market, China, 2023-2030" report has been added to ResearchAndMarkets.com's offering. The…

2 days ago

Private Meets Public: Kensington Private Hospital is Setting a New Standard for GI Documentation with Provation MD Software

NORTHLAND, New Zealand--(BUSINESS WIRE)--#ClinicalDocumentation--Kensington Private Hospital has implemented Provation® MD, a market-leading GI procedure documentation…

2 days ago

Pan American Silver to Announce First Quarter 2025 Unaudited Results and Host Annual General and Special Meeting of Shareholders on May 7

VANCOUVER, British Columbia--(BUSINESS WIRE)--Pan American Silver Corp. (NYSE: PAAS) (TSX: PAAS) ("Pan American") will announce…

2 days ago

Lifezone Metals Announces 2024 Financial Results and Filing of Form 20-F

  NEW YORK--(BUSINESS WIRE)--$LZM #BatteryMetals--Lifezone Metals Limited’s (NYSE: LZM) Chief Financial Officer, Ingo Hofmaier, announces…

2 days ago